Thursday, July 31, 2008 1:19:51 PM
Thursday July 31, 1:30 am ET
BRISBANE, Calif.--(BUSINESS WIRE)--Tercica, Inc. (Nasdaq: TRCA - News) today announced financial results for the quarter ended June 30, 2008. Net product sales totaled $6.2 million, compared to $2.0 million in the second quarter of 2007. Net product sales for Increlex® and Somatuline® Depot in the second quarter of 2008 were $4.6 million and $1.6 million, respectively.
Net loss for the second quarter of 2008 was $11.4 million, or $0.22 per share, compared to a net loss of $12.8 million, or $0.26 per share, for the second quarter of 2007.
Cash, cash equivalents and short-term investments as of June 30, 2008 were $71.4 million, compared to $94.9 million as of March 31, 2008.
Company Updates
Agreement and Plan of Merger with Ipsen.
On June 4, 2008, Tercica announced that Tercica and an affiliate of Ipsen, S.A. entered into an agreement and plan of merger by which an affiliate of Ipsen would acquire all of the shares of Tercica common stock that Ipsen does not currently own at a price of $9.00 per share in cash.
On July 24, 2008, Tercica announced the expiration of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act and clearance by the German antitrust regulatory authority in connection with the agreement and plan of merger. Assuming satisfaction of the closing conditions in the agreement and plan of merger, including stockholder approval, Tercica estimates that the completion of the merger transaction should take effect late in the third quarter or early in the fourth quarter of 2008.
On July 24, 2008, Tercica also announced that Ipsen exercised in full the warrant issued by Tercica in October 2006, converted in full three convertible notes issued by Tercica in October 2006 and September 2007, and purchased 410,831 additional shares of the common stock of Tercica upon exercise of its pro rata rights to purchase shares in connection with other equity issuances by Tercica. Total cash proceeds from the warrant exercise and purchase of additional shares by Ipsen were $40.3 million.
http://biz.yahoo.com/bw/080731/20080730006479.html?.v=1
Recent TRCA News
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/20/2023 10:14:44 PM
- Form 15-12G - Securities registration termination [Section 12(g)] • Edgar (US Regulatory) • 11/13/2023 05:00:12 PM
- Form 425 - Prospectuses and communications, business combinations • Edgar (US Regulatory) • 10/31/2023 08:15:48 PM
- Form 425 - Prospectuses and communications, business combinations • Edgar (US Regulatory) • 10/27/2023 08:15:55 PM
- Form 425 - Prospectuses and communications, business combinations • Edgar (US Regulatory) • 10/19/2023 08:33:10 PM
- Carbon Revolution Announces Major Milestones in its Business Combination with Twin Ridge Capital Acquisition Corp. • Business Wire • 10/19/2023 10:30:00 AM
- Form 425 - Prospectuses and communications, business combinations • Edgar (US Regulatory) • 10/18/2023 08:09:09 PM
- Form 425 - Prospectuses and communications, business combinations • Edgar (US Regulatory) • 10/16/2023 08:37:05 PM
- Form 425 - Prospectuses and communications, business combinations • Edgar (US Regulatory) • 10/16/2023 08:35:13 PM
- Form 425 - Prospectuses and communications, business combinations • Edgar (US Regulatory) • 10/16/2023 08:32:26 PM
- Form 425 - Prospectuses and communications, business combinations • Edgar (US Regulatory) • 10/13/2023 09:27:17 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/13/2023 09:25:09 PM
- Form 425 - Prospectuses and communications, business combinations • Edgar (US Regulatory) • 10/13/2023 08:15:49 PM
- Form 425 - Prospectuses and communications, business combinations • Edgar (US Regulatory) • 10/10/2023 08:44:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/10/2023 08:40:09 PM
- Form 425 - Prospectuses and communications, business combinations • Edgar (US Regulatory) • 10/10/2023 08:30:04 PM
- Form 425 - Prospectuses and communications, business combinations • Edgar (US Regulatory) • 10/06/2023 08:17:47 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/05/2023 09:20:12 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 10/05/2023 09:15:23 PM
- Form 425 - Prospectuses and communications, business combinations • Edgar (US Regulatory) • 10/03/2023 09:00:50 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/03/2023 09:00:29 PM
- Form 425 - Prospectuses and communications, business combinations • Edgar (US Regulatory) • 10/02/2023 09:14:35 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/02/2023 09:08:15 PM
- Form 425 - Prospectuses and communications, business combinations • Edgar (US Regulatory) • 10/02/2023 08:26:36 PM
- Form 425 - Prospectuses and communications, business combinations • Edgar (US Regulatory) • 10/02/2023 08:22:56 PM
FEATURED Integrated Ventures Files Q3/2024 With Mining Revenues Of $1,983,250 And Positive Earnings Of $0.05 Cents Per Share • May 15, 2024 10:30 AM
Swifty Global Announces Impressive Financial Results for Q1 2024 • DRCR • May 15, 2024 10:25 AM
Branded Legacy Inc. Invites Shareholders to Celebrate Milestones at Open House: Announces Share Buyback and Commitment to Authorized Share Count • BLEG • May 15, 2024 8:30 AM
Alliance Creative Group (ACGX) Releases Q1 2024 Financial and Disclosure Report with an 88% increase in Net Income from Q1 2023 to Q1 2024 • ACGX • May 15, 2024 8:30 AM
Category V Biotech, Inc. Announces Letter of Intent to Acquire Genetic Networks, Expanding into Biotechnology Sector • CATV • May 15, 2024 8:00 AM
POET Announces Design Win and Collaboration with Foxconn Interconnect Technology for High-speed AI Systems • POET • May 14, 2024 10:09 AM